University Of Maryland, Baltimore

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Established: 1807-01-01

Employees: 7.3K

Market Cap: -

Website: http://www.umaryland.edu

Clinical Trials

The Effect of Donepezil on Glycemic Control in Type II Diabetics

Phase 2

Terminated

Conditions: Diabetes Mellitus, Type 2

Interventions: Drug: Donepezil 5-10 Mg Oral Tablet
Drug: Placebo Oral Tablet

First Posted Date: 2020-08-11

Last Posted Date: 2023-10-13

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 7

Registration Number: NCT04507438

Locations: 🇺🇸
University of Maryland Shore Regional Health, Easton, Maryland, United States

The Effect of Donepezil on Wound Healing

Phase 2

Recruiting

Conditions: Wound Heal

Interventions: Drug: Donepezil
Drug: Placebo oral tablet
Drug: Topical Zinc Oxide

First Posted Date: 2020-08-10

Last Posted Date: 2023-05-22

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 20

Registration Number: NCT04505670

Locations: 🇺🇸
University of Maryland Shore Medical Center at Easton, Easton, Maryland, United States

Prehospital Norepinephrine and Early Mortality in Traumatic Shock

Completed

Conditions: Hypotension and Shock
Traumatic Brain Injury
Hemorrhagic Shock
Traumatic Shock

Interventions: Drug: Norepinephrine

First Posted Date: 2020-08-04

Last Posted Date: 2022-02-10

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 2164

Registration Number: NCT04497155

Hypofractionated Accelerated Pelvic Nodal Radiotherapy (GCC 2048)

Phase 1

Recruiting

Conditions: Prostate Adenocarcinoma
Prostate Cancer

Interventions: Radiation: Hypofractionated Radiation Therapy

First Posted Date: 2020-07-27

Last Posted Date: 2024-05-07

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 18

Registration Number: NCT04486755

Locations: 🇺🇸
Maryland Proton Treatment Center, Baltimore, Maryland, United States

Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)

Phase 2

Withdrawn

Conditions: Disorder Related to Lung Transplantation
Chronic Rejection of Lung Transplant
Decreased Immunologic Activity

Interventions: Drug: Assigned Interventions

First Posted Date: 2020-06-04

Last Posted Date: 2023-05-06

Lead Sponsor: University of Maryland, Baltimore

Registration Number: NCT04415476

Measuring the Effects of Rhopressa on Episcleral and Retinal Blood Flow in Ocular Hypertension and Glaucoma Suspects

Completed

Conditions: Ocular Hypertension
Suspect Glaucoma

Interventions: Drug: Netarsudil ophthalmic solution 0.02% one drop nightly for 1-2 weeks

First Posted Date: 2020-05-26

Last Posted Date: 2022-03-28

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 10

Registration Number: NCT04401982

Locations: 🇺🇸
Maryland Eye Consultants and Surgeons, Silver Spring, Maryland, United States
🇺🇸
UM Faculty Physicians, Inc. | 5900 Waterloo Crossing, Columbia, Maryland, United States
🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

and more 1 locations

Trial of Imatinib for Hospitalized Adults With COVID-19

Phase 3

Active, not recruiting

Conditions: COVID-19

Interventions: Drug: Placebo oral tablet
Drug: Imatinib

First Posted Date: 2020-05-19

Last Posted Date: 2024-08-27

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 204

Registration Number: NCT04394416

Locations: 🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Pilot Testing a Digital Intervention to Improve Smoking Cessation in Persons With Serious Mental Illness

Not Applicable

Active, not recruiting

Conditions: Tobacco Cessation

Interventions: Behavioral: BecomeAnEX
Behavioral: Usual Care

First Posted Date: 2020-04-29

Last Posted Date: 2024-12-27

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 59

Registration Number: NCT04367506

Locations: 🇺🇸
Melanie Bennett, Baltimore, Maryland, United States
🇺🇸
University of Maryland School of Medicine, Baltimore, Maryland, United States

Adjunct VR Pain Management in Acute Brain Injury

Not Applicable

Completed

Conditions: Pain, Acute
Trauma
Traumatic Brain Injury
Headaches Posttraumatic

Interventions: Behavioral: Virtual Reality Session (VR Blu)
Behavioral: Tablet-based Session (Tablet Blu)
Behavioral: Use of Virtual Reality Head Mounted Display without Content (VR Blank)

First Posted Date: 2020-04-22

Last Posted Date: 2023-04-24

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 60

Registration Number: NCT04356963

Locations: 🇺🇸
R Adams Cowley Shock Trauma Center, Baltimore, Maryland, United States
🇺🇸
University of Maryland Medical Center, Baltimore, Maryland, United States

Glucagon-like Peptide-1 in Type 1 Diabetes

Early Phase 1

Recruiting

Conditions: Type1 Diabetes Mellitus

Interventions: Drug: Placebos
Drug: Glucagon-like peptide-1

First Posted Date: 2020-04-21

Last Posted Date: 2024-11-05

Lead Sponsor: University of Maryland, Baltimore

Target Recruit Count: 40

Registration Number: NCT04355832

Locations: 🇺🇸
University of Maryland, Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy